Cargando…

Lower DLco% identifies exercise pulmonary hypertension in patients with parenchymal lung disease referred for dyspnea

Exercise pulmonary hypertension is an underappreciated form of physical limitation related to early pulmonary vascular disease. A low diffusing capacity of lungs for carbon monoxide (DLco) can be seen in patients with resting pulmonary hypertension as well as parenchymal lung disease. It remains unc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Richard H., Wallace, William D., Nouraie, S. Mehdi, Chan, Stephen Y., Risbano, Michael G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031800/ https://www.ncbi.nlm.nih.gov/pubmed/32128158 http://dx.doi.org/10.1177/2045894019891912

Ejemplares similares

Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility
por: Wallace, William D., et al.
Publicado: (2018)

Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis
por: Sivova, Nadia, et al.
Publicado: (2013)

The prognostic value of DLCO and pulmonary blood flow in patients with pulmonary hypertension
por: Stadler, Stefan, et al.
Publicado: (2019)

Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study
por: Wu, Wen-Jui, et al.
Publicado: (2022)

The added value of haemoglobin to height, age, and sex to predict DLCO in subjects with preserved exercise capacity
por: Priel, Eldar, et al.
Publicado: (2023)

Pulmonary Hypertension in Parenchymal Lung Disease
por: Tsangaris, Iraklis, et al.
Publicado: (2012)

T Lymphocyte Maturation Profile in the EBUS-TBNA Lymph Node Depending on the DLCO Parameter in Patients with Pulmonary Sarcoidosis
por: Rutkowska, Elżbieta, et al.
Publicado: (2021)

Overview of current therapeutic approaches for pulmonary hypertension
por: Stamm, Jason A., et al.
Publicado: (2011)

A syndrome of severe idiopathic pulmonary parenchymal disease with pulmonary hypertension in Pekingese
por: Köster, Liza S, et al.
Publicado: (2016)

Respiratory system as the main determinant of dyspnea in patients with pulmonary hypertension
por: Mitrouska, Ioanna, et al.
Publicado: (2022)

Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass
por: Velasco-Torres, Yadira, et al.
Publicado: (2019)

Exercise dyspnea in patients with COPD
por: Stendardi, Loredana, et al.
Publicado: (2007)

One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome
por: Fortini, Alberto, et al.
Publicado: (2022)

Restrictions of VC and DLCO in relation to asbestos-related computed tomographic findings quantified by ICOERD-based parameters
por: Ströker, Lennart, et al.
Publicado: (2022)

Breathing too much! Ventilatory inefficiency and exertional dyspnea in pulmonary hypertension
por: Neder, José Alberto, et al.
Publicado: (2022)

Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients
por: Costi, Stefania, et al.
Publicado: (2019)

Unexpected radiation pneumonitis after SIRT with significant decrease in DLCO with internal radiation exposure: a case report
por: Kesim, Selin, et al.
Publicado: (2020)

Dyspnea, depression and health related quality of life in pulmonary arterial hypertension patients
por: Talwar, Arunabh, et al.
Publicado: (2015)

Inspiratory muscle weakness contributes to exertional dyspnea in chronic thromboembolic pulmonary hypertension
por: Rolim, João Victor, et al.
Publicado: (2018)

The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension
por: Banerjee, Debasree, et al.
Publicado: (2017)

Thyrotoxicosis presenting as exertional dyspnea and pulmonary hypertension: Case report and review of literature
por: Rashidi, Farid, et al.
Publicado: (2017)

Measures of dyspnea in pulmonary rehabilitation
por: Crisafulli, Ernesto, et al.
Publicado: (2010)

Undiagnosed dyspnea with pulmonary nodule
por: Tsou, Cheng‐Hsien, et al.
Publicado: (2023)

Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension
por: Coons, James C., et al.
Publicado: (2017)

Differentiating Cardiac and Pulmonary Causes of Dyspnea Using Ultrasonography and Dyspnea Discrimination Index
por: Chandy, Gina M, et al.
Publicado: (2022)

Dyspnea and quality of life in patients referred for lung transplantation
por: Lutogniewska, W, et al.
Publicado: (2010)

Measurement of diffusion lung capacity (DLCO) in silicosis patients: Correlation with radiographic abnormalities on high-resolution CT scan chest
por: Dixit, Ramakant, et al.
Publicado: (2022)

Mechanism of Dyspnea during Exercise in Children with Corrected Congenital Heart Disease
por: Chlif, Mehdi, et al.
Publicado: (2021)

Comparison between quantitative computed tomography, scintigraphy, and anatomical methods for prediction of postoperative FEV(1) and DLCO: effects of chronic obstructive pulmonary disease status and resected lobes
por: Yokoba, Masanori, et al.
Publicado: (2020)

Cardiopulmonary exercise testing in the assessment of exertional dyspnea
por: Datta, Debapriya, et al.
Publicado: (2015)

Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults
por: Howarth, Timothy, et al.
Publicado: (2021)

Isolated abnormal diffusing capacity for carbon monoxide (iso↓DLco) is associated with increased respiratory symptom burden in people with HIV infection
por: Byanova, Katerina L., et al.
Publicado: (2023)

Pulmonary Parenchymal Changes in COVID-19 Survivors
por: Diaz, Ashley, et al.
Publicado: (2022)

Pulmonary parenchymal involvement caused by Tropheryma whipplei
por: Zhang, Wen Mei, et al.
Publicado: (2021)

DIFFUSE PARENCHYMAL LUNG DISEASE AND PULMONARY CIRCULATION
Publicado: (2022)

Diffuse Parenchymal Lung Disease and Pulmonary Circulation
Publicado: (2022)

The Assessment of Dyspnea during the Vigorous Intensity Exercise by Three Dyspnea Rating Scales in Inactive Medical Personnel
por: Intarakamhang, Patrawut, et al.
Publicado: (2013)

Improved hospitalization rates in a specialty center for heart failure with preserved ejection fraction and pulmonary hypertension
por: Kosanovich, Chad M., et al.
Publicado: (2022)

A 45-Year-Old Man With Recurrent Dyspnea and Hemoptysis during Exercise: Exercise-Induced Pulmonary Hemorrhage/Edema
por: Kim, Dae Sung, et al.
Publicado: (2015)

Tiotropium and exercise training in COPD patients: Effects on dyspnea and exercise tolerance
por: Ambrosino, Nicolino, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ism41h8m4b8pv8gnek5eptoo8a